Diamond Hill Capital Management Inc. Boosts Stock Holdings in Revvity Inc. $RVTY

Diamond Hill Capital Management Inc. boosted its stake in shares of Revvity Inc. (NYSE:RVTY) by 6.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 426,899 shares of the company’s stock after acquiring an additional 25,233 shares during the period. Diamond Hill Capital Management Inc.’s holdings in Revvity were worth $41,302,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of RVTY. AQR Capital Management LLC grew its stake in Revvity by 5.2% during the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after acquiring an additional 420 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Revvity by 6.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock valued at $1,246,000 after acquiring an additional 744 shares in the last quarter. Millennium Management LLC grew its stake in Revvity by 102.0% during the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock valued at $7,343,000 after acquiring an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Revvity by 45.5% during the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after acquiring an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth grew its stake in Revvity by 13.0% during the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after acquiring an additional 811 shares in the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Price Performance

RVTY stock opened at $95.41 on Friday. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $118.30. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average price of $90.54 and a 200 day moving average price of $96.96. The stock has a market cap of $10.64 billion, a PE ratio of 45.65, a P/E/G ratio of 2.04 and a beta of 1.05.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. During the same period in the previous year, the company earned $1.01 EPS. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities research analysts anticipate that Revvity Inc. will post 5.33 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s payout ratio is currently 13.40%.

Analyst Ratings Changes

Several equities analysts recently weighed in on RVTY shares. Evercore raised their target price on shares of Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research note on Tuesday, February 3rd. JPMorgan Chase & Co. cut their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Barclays raised their target price on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Stifel Nicolaus cut their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. Finally, TD Cowen raised their target price on shares of Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Four investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Revvity presently has an average rating of “Hold” and a consensus target price of $107.73.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.